092730.KQ
NeoPharm Co. Ltd.
KOE · Consumer Defensive · Household & Personal Products · KR
KRW 23,150.00
−2.94%Margins
Gross margin
65.6%
EBITDA margin
27.0%
EBIT margin
21.9%
Net margin
20.7%
FCF margin
18.8%
15.2%
Return on equity
13.5%
Return on assets
16.0%
Return on invested capital
0.66x
Asset turnover
KRW 29.4B
Cash from operations
KRW 9.1K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026